IL1B and Menkes disease: Our group found two subgroups of MD patients according to the baseline levels of IL-1β, differentiating patients with high levels of IL-1β (MDH) and patients with low levels (MDL), who in turn may have different immune response profiles to antigens or even differences in the functional status of the immune system [7].